[VRTX] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
30-Oct-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -672.08%
YoY- -146.06%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 752,157 640,799 651,634 578,165 544,135 714,718 458,706 39.17%
PBT 216,591 214,642 112,442 -417,170 35,506 253,533 20,306 386.66%
Tax 10,341 -12,659 10,257 -125,903 4,337 3,985 -7,453 -
NP 207,360 210,263 100,684 -102,952 17,996 247,756 32,945 242.04%
Tax Rate -4.77% 5.90% -9.12% - -12.21% -1.57% 36.70% -
Total Cost 544,797 430,536 550,950 681,117 526,139 466,962 425,761 17.91%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 27.57 32.81 15.45 -17.81 3.31 34.66 7.18 145.81%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS 0.82 0.83 0.40 -0.41 0.07 1.01 0.13 242.54%
EPS Diluted 0.80 0.81 0.39 -0.41 0.07 0.99 0.13 236.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.